Showing results (11-20 of 167) with videos related to
Sort By:
Pageof 17
Journal of Neurology|March 30, 2020
Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodiesBastien Joubert, Aude Belbezier, Julie Haesebaert, et al.British Journal of Clinical Pharmacology|August 26, 2022
Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance studyAlberto Picca, Cristina Birzu, Giulia Berzero, et al.European Journal of Neurology|November 3, 2023
Hypersomnia in anti-glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot studyLina Jeantin, Ana Gales, Giulia Berzero, et al.Presse Medicale (Paris, France : 1983)|March 16, 2026
Neurological immune-related adverse events of immune-checkpoint inhibitors: an updated reviewAlberto Picca, Dimitri PsimarasBritish Journal of Cancer|June 15, 2018
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodiesClément Vialatte de Pémille, Giulia Berzero, Mathilde Small, et al.The Oncologist|October 17, 2019
Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the LiteratureEvangelia Pappa, Giulia Berzero, Bastien Herlin, et al.Neurology(R) Neuroimmunology & Neuroinflammation|March 15, 2020
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodiesClaire Simard, Alberto Vogrig, Bastien Joubert, et al.Neurology(R) Neuroimmunology & Neuroinflammation|August 28, 2020
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in FranceJulien Hébert, Benjamin Riche, Alberto Vogrig, et al.Journal of Neurology|November 22, 2018
Isolated seizures are a common early feature of paraneoplastic anti-GABAB receptor encephalitisAurélien Maureille, Tanguy Fenouil, Bastien Joubert, et al.Pageof 17